# Anti-Mullerian Hormone (AMH) is a Marker for Ovarian Reserve. There Are Many Studies About AMH Changes in Ovarian Surgery, But Little is Known for Other Surgeries. We Seek to Investigate the Hormone Variations Before and After Uterine Artey Ligation for Postpartum Hemorrage (PPH)

> **NCT03907605** · — · COMPLETED · sponsor: **Kanuni Sultan Suleyman Training and Research Hospital** · enrollment: 88 (actual)

## Conditions studied

- Anti-Mullerian Hormone Deficiency
- Post Partum Hemorrhage

## Interventions

- **OTHER:** anti- mullerian hormone

## Key facts

- **NCT ID:** NCT03907605
- **Lead sponsor:** Kanuni Sultan Suleyman Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2019-03-01
- **Final completion:** 2019-04-01
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2019-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03907605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03907605, "Anti-Mullerian Hormone (AMH) is a Marker for Ovarian Reserve. There Are Many Studies About AMH Changes in Ovarian Surgery, But Little is Known for Other Surgeries. We Seek to Investigate the Hormone Variations Before and After Uterine Artey Ligation for Postpartum Hemorrage (PPH)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03907605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*